Table 3 Comparison of macroeconomic loss (measured in 2017 INT$) and lifetime disease burden (measured in DALYs) by World Bank region and World Bank income group
Region/income group | Economic cost in billions of 2017 INT$ | DALYs in millions in 2020 | DALYs in millions in 2050 | Annual GDP in billions 2020–2050 | Annual population in millions 2020–2050 |
|---|---|---|---|---|---|
By region | |||||
East Asia and Pacific | 3,104 (30.39%) | 21 (28.81%) | 38 (23.25%) | 52,763 (35.70%) | 2,461 (27.87%) |
Europe and Central Asia | 2,017 (19.75%) | 9 (12.75%) | 15 (9.06%) | 30,825 (20.86%) | 930 (10.54%) |
Latin America and Caribbean | 629 (6.16%) | 9 (12.59%) | 22 (13.66%) | 8,869 (6.00%) | 718 (8.13%) |
Middle East and North Africa | 487 (4.77%) | 4 (5.65%) | 14 (8.70%) | 8,163 (5.52%) | 562 (6.36%) |
North America | 2,594 (25.40%) | 5 (6.64%) | 7 (4.16%) | 21,720 (14.70%) | 399 (4.52%) |
South Asia | 1,218 (11.92%) | 18 (24.53%) | 49 (30.22%) | 19,983 (13.52%) | 2,111 (23.90%) |
Sub-Saharan Africa | 163 (1.60%) | 7 (8.96%) | 18 (10.78%) | 5,420 (3.67%) | 1,642 (18.59%) |
By income group | |||||
Low income | 65 (0.64%) | 4 (4.99%) | 12 (7.07%) | 2,068 (1.40%) | 962 (10.90%) |
Lower-middle income | 2,296 (22.48%) | 32 (44.04%) | 89 (54.92%) | 35,950 (24.32%) | 3,938 (44.59%) |
Upper-middle income | 2,672 (26.17%) | 23 (31.68%) | 40 (24.82%) | 51,967 (35.16%) | 2,650 (30.01%) |
High income | 5,151 (50.43%) | 14 (18.64%) | 20 (12.29%) | 57,446 (38.87%) | 1,238 (14.03%) |
Sum | 10,214 (100.00%) | 73 (100.00%) | 163 (100.00%) | 147,771 (99.98%) | 8,830 (99.99%) |
